These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 136827)

  • 1. Absence of carcinogenic effects of estradiol mustard (NSC-112259) in rats.
    Schmähl D; Habs M
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976; 87(2):197-8. PubMed ID: 136827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cancer chemotherapeutic agents on endocrine organs and serum levels of estrogens, progesterone, prolactin, and luteinizing hormone.
    Kuo EY; Esber HJ; Taylor DJ; Bogden AE
    Cancer Res; 1975 Aug; 35(8):1975-80. PubMed ID: 125149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology and carcinogenesis studies of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Jan; (545):1-240. PubMed ID: 18685716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity in beagle dogs of three alkylating esters with antitumor activity: phenesterin (NSC-104469), estradiol mustard (NSC-112259), and dehydroepiandrosterone mustard (NSC-12121).
    Schaeppi U; Heyman IA; Fleischman RW; Rosenkrantz H; Ilievski V; Phelan R; Cooney DA; Davis RD
    Cancer Chemother Rep 3; 1973 Jan; 4(1):85-95. PubMed ID: 4267410
    [No Abstract]   [Full Text] [Related]  

  • 5. Estradiol mustard (NSC-112259) and phenester (NSC-116785): possible mediation of action by estrogen binding protein.
    Everson RB; Turnell RW; Wittliff JL; Hall TC
    Cancer Chemother Rep; 1974; 58(3):353-7. PubMed ID: 4366835
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-implantation activity of antiestrogens and mifepristone.
    Dao B; Vanage G; Marshall A; Bardin CW; Koide SS
    Contraception; 1996 Oct; 54(4):253-8. PubMed ID: 8922879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testing of the carcinogenic effect of nitrogen mustard oxide on rats].
    STEINHOFF D; KUK BT
    Z Krebsforsch; 1957; 62(2):112-5. PubMed ID: 13531430
    [No Abstract]   [Full Text] [Related]  

  • 8. Occurrence of tumors in mice injected subcutaneously with sulfur mustard and nitrogen mustard.
    HESTON WE
    J Natl Cancer Inst; 1953 Aug; 14(1):131-40. PubMed ID: 13097144
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo interaction between steroidal alkylating agents and oestrogen receptors in rabbit uteri.
    Asai M; Takeuchi H; Okada H
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):173-80. PubMed ID: 579532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carcinogenic properties of some of the principal drugs used in clinical cancer chemotherapy.
    Weisburger JH; Griswold DP; Prejean JD; Casey AE; Wood HB; Weisburger EK
    Recent Results Cancer Res; 1975; (52):1-17. PubMed ID: 138176
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of cortiphen and cyclophosphamide in uterine sarcoma induced primarily by 1,2-dimethylhydrazine and estradiol dipropionate in CBA mice].
    Merkulova IB; Vvedenskaia NA; Kiselev VI
    Eksp Onkol; 1990; 12(1):68-70. PubMed ID: 2298148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multigenerational reproductive study of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Mar; (539):1-266. PubMed ID: 18685713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. URACIL MUSTARD: A POTENT INDUCER OF LUNG TUMORS IN MICE.
    ABELL CW; FALK HL; SHIMKIN MB; WEISBURGER EK; WEISBURGER JH; GUBAREFF N
    Science; 1965 Mar; 147(3664):1443-5. PubMed ID: 14268720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestradiol mustard.
    IARC Monogr Eval Carcinog Risk Chem Man; 1975; 9():217-21. PubMed ID: 791835
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinogenic action of the mustards.
    HESTON WE
    J Natl Cancer Inst; 1950 Oct; 11(2):415-23. PubMed ID: 14795195
    [No Abstract]   [Full Text] [Related]  

  • 16. New estradiol-linked nitrosoureas: can the pharmacokinetic properties help to explain the pharmacodynamic activities?
    Betsch B; Berger MR; Spiegelhalder B; Eisenbrand G; Schmähl D
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):105-11. PubMed ID: 2920758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of mutagenic and carcinogenic activities of aniline mustards.
    Leo A; Panthananickal A; Hansch C; Theiss J; Shimkin M; Andrews AW
    J Med Chem; 1981 Jul; 24(7):859-64. PubMed ID: 7277394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
    Zeller WJ; Schreiber J; Petru E; Eisenbrand G
    Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological tests of carcinogenic activity.
    Shimkin MB
    Arch Environ Health; 1968 Apr; 16(4):522-30. PubMed ID: 4172449
    [No Abstract]   [Full Text] [Related]  

  • 20. Estrogen receptor interaction with the antitumor agent estradiol mustard.
    Shepherd RE; Huff K; McGuire WL
    J Natl Cancer Inst; 1974 Sep; 53(3):895-7. PubMed ID: 4370003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.